Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Dédée F. Murrell, Sarah Dick, A. R. Ahmed et al. · Journal of the American Academy of Dermatology · 2008 · 589 citations · Full text

Medicine, Immunology, Pathology +13

The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels

Kristyn Harman, Paul T. Seed, Matthew J. Gratian et al. · British Journal of Dermatology · 2001 · 269 citations

Medicine, Dermatology, Pathology +15

Guidelines

Kristyn Harman, Sandra Albert, Martin M. Black · British Journal of Dermatology · 2003 · 261 citations · Full text

Medicine, Dermatology, Dermatopathology +6

Pemphigus. S2 Guideline for diagnosis and treatment – guided by the European Dermatology Forum (<scp>EDF</scp>) in cooperation with the European Academy of Dermatology and Venereology (<scp>EADV</scp>)

Michael Hertl, Hana Jedličková, Sarolta Kárpáti et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 254 citations · Full text

Medicine, Dermatology, Autoimmunity +16

ELISA Testing of Anti–Desmoglein 1 and 3 Antibodies in the Management of Pemphigus

C. Abasq, Hugo Mouquet, Danièle Gilbert et al. · Archives of Dermatology · 2009 · 155 citations

Medicine, Dermatology, Pathology +17